Vitamins E and C for the treatment of NASH: duplication of results but lack of demonstration of efficacy

Adams, Leon A.; Angulo, Paul
November 2003
American Journal of Gastroenterology;Nov2003, Vol. 98 Issue 11, p2348
Academic Journal
No abstract available.


Related Articles

  • Pioglitazone vs vitamin E for NASH.  // Critical Care Alert;Jul2010 Pharmacology, p2 

    The article presents a study on the compares the superior efficacy of vitamin E than thiazolidinedione pioglitazone for the treatment of patients with non-alcoholic steatohepatitis (NASH).

  • Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Harrison, Stephen A.; Torgerson, Sigurd; Hayashi, Paul; Ward, John; Schenker, Steven // American Journal of Gastroenterology;Nov2003, Vol. 98 Issue 11, p2485 

    : ObjectiveNonalcoholic steatohepatitis (NASH) is a common cause of liver disease. Although usually indolent, this disease can progress to cirrhosis in some patients. There is currently no proven medical therapy for the treatment of NASH. The aim of our study was to evaluate the efficacy of...

  • Study shows vitamin E fails to slow progress of AD but Aricept effective in first 12 months of treatment.  // Canadian Nursing Home;Jun/Jul2005, Vol. 16 Issue 2, p23 

    Reports on a study on the efficacy of vitamin E for the treatment of Alzheimer's disease (AD). Failure of vitamin E to slow progress of AD; Efficacy demonstrated by Aricept drug in slowing the rate of AD progression during the first 12 months of treatment.

  • Pioglitazone vs vitamin E for NASH. Elliott, William T. // Neurology Alert;Jul2010 Pharmacology Watch, p2 

    The article discusses a research study which compared the efficacy of pioglitazone against vitamin E as treatment for non-alcoholic steatohepatitis (NASH), referencing a study published in a 2010 issue of the "New England Journal of Medicine."

  • Pioglitazone vs vitamin E for NASH. Elliot, William T. // Infectious Disease Alert;Jul2010 Supplement, p2 

    The article discusses a research study on the efficacy of thiazolidinedione pioglitazone and vitamin E against non-alcoholic steatohepatitis (NASH).

  • Treating Influenza with Vitamin C: Results and Mechanisms. Levy, Thomas E. // Townsend Letter;Dec2012, Issue 353, p74 

    The article focuses on the results and mechanisms of the treatment of influenza with Vitamin C. It says that doctor Frederick R. Klenner has first used Vitamin C in a viral pneumonia patient, demonstrating a cleaned breathing characteristic. It states the efficacy of Vitamin C to destroy or...

  • Vitamin E Beats Drug Treatment for Liver Disease. Dye, Dayna // Life Extension;Feb2010, Vol. 16 Issue 2, p16 

    The article discusses results of a research trial which found that vitamin E was more effective than the antidiabetic drug pioglitazone for the treatment of non-alcoholic steatohepatitis (NASH).

  • Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E. Ni, Yinhua; Nagashimada, Mayumi; Zhuge, Fen; Zhan, Lili; Nagata, Naoto; Tsutsui, Akemi; Nakanuma, Yasuni; Kaneko, Shuichi; Ota, Tsuguhito // Scientific Reports;11/27/2015, p17192 

    Hepatic insulin resistance and nonalcoholic steatohepatitis (NASH) could be caused by excessive hepatic lipid accumulation and peroxidation. Vitamin E has become a standard treatment for NASH. However, astaxanthin, an antioxidant carotenoid, inhibits lipid peroxidation more potently than vitamin...

  • Does Vitamin E Improve the Outcomes of Pediatric Nonalcoholic Fatty Liver Disease? A Systematic Review and Meta‑analysis. Sarkhy, Ahmed A.; Al‑Hussaini, Abdulrahman A.; Nobili, Valerio // Saudi Journal of Gastroenterology;May/Jun2014, Vol. 20 Issue 3, p143 

    Background and Aims: To systemically evaluate the efficacy of adjuvant vitamin E on the outcomes of nonalcoholic fatty liver disease (NAFLD) and/or nonalcoholic steatohepatitis (NASH) in children. Materials and Methods: We searched MEDLINE, PUBMED, EMBASE, the Cochrane Central Register...

  • Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study. Kawanaka, Miwa; Nishino, Ken; Nakamura, Jun; Suehiro, Mitsuhiko; Goto, Daisuke; Urata, Noriyo; Oka, Takahito; Kawamoto, Hirofumi; Nakamura, Hajime; Yodoi, Junji; Hino, Keisuke; Yamada, Gotaro // Hepatic Medicine: Evidence & Research;2013, Vol. 5, p11 

    Background: Nonalcoholic steatohepatitis (NASH) is a common liver disease that can progress to cirrhosis. Oxidative stress is one of the central mechanisms causing hepatocellular injury in the disease. In this study, antioxidant therapy using both vitamins C and E was conducted in patients with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics